Inventor

KELER TIBOR

US33 patents

⚠️ This page may combine multiple inventors who share the name “KELER TIBOR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KELER TIBOR

CELLDEX THERAPEUTICS INC

Agonistic antibodies that bind CD40

Human monoclonal antibodies to dendritic cells

Antibodies that bind human CD27 and uses thereof

Methods of inducing or enhancing an immune response comprising administering agonistic anti-CD40 antibodies

Nucleic acids encoding agonistic antibodies that bind CD40

Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs

Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs

Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)

Agonistic antibodies that bind human CD40 and uses thereof

Cells expressing anti-Fc receptor binding components

Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)

KELER TIBOR

Antibodies that bind human CD27 and uses thereof

Antibody vaccine conjugates and uses therefor

Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)

Antibodies against human melanoma-associated chondroitin sulphate proteoglycan (MCSP)

Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)

Human monoclonal antibodies against CD30

Antibody vaccine conjugates and uses therefor

Human monoclonal antibodies against Bacillus anthracis protective antigen

MEDAREX INC

Therapeutic multispecific compounds comprised of anti-FCA receptor antibodies

Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies

Cells expressing anti-Fc receptor binding components

Therapeutic compounds comprised of anti-FC receptor binding agents

Human monoclonal antibodies against CD30

Human monoclonal antibodies against Bacillus anthracis protective antigen

BRISTOL MYERS SQUIBB CO

Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment

Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment

Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment

DEO YASHWANT M

Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells

Monoclonal antibodies to dendritic cells

MEDERAX INC

Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies

CELLDEX RES CORP

Molecular conjugates comprising human monoclonal antibodies to dendritic cells

CELDARA MEDICAL LLC

Chimeric antigen receptors targeting TIM-1